AI Terminal
Eckert & Ziegler Strahlen- und Medizintechnik AG
Share Issue/Capital Change • Aug 5, 2025
130_rns_2025-08-05_a9cb3bf0-345e-4aef-8167-6932a0863574.html
Share Issue/Capital Change
Open in ViewerOpens in native device viewer
News Details
Corporate | 5 August 2025 11:50
Eckert & Ziegler: Implementation of the Share Split by Issuing Bonus Shares to Be Effective on 15 August 2025
Eckert & Ziegler SE / Key word(s): Corporate Action
Eckert & Ziegler: Implementation of the Share Split by Issuing Bonus Shares to Be Effective on 15 August 2025
05.08.2025 / 11:50 CET/CEST
The issuer is solely responsible for the content of this announcement.
Berlin, 5 August 2025. All formal requirements of the stock split resolved by the Annual General Meeting on 18 June 2025 have now been met and the timeline for implementation of this capital measure of Eckert & Ziegler SE (ISIN DE0005659700) on the bank side is set.
Accordingly, the company’s shareholders will be entitled to new shares in the ratio of 1:2 based on their shareholdings in the ISIN DE0005659700 on August 14, 2025 (record date), after the close of trading, i.e., two additional shares will be issued for each old share free of charge. The new shares will be allocated by the respective custodian banks to the entitled shareholders on August 15 (payment date) by means of a credit entry to their securities accounts, taking into account any outstanding stock exchange transactions.
This will triple the number of tradable shares with the aim of optimizing the liquidity of Eckert & Ziegler shares. This will not change the respective percentage share of a shareholder in the capital of Eckert & Ziegler SE.
As all shares of Eckert & Ziegler SE are held in in a collective custody account, shareholders do not need to take any action to receive the new shares. The new shares will be included in the existing listing on the Frankfurt Stock Exchange on August 13, 2025.
The new shares carry dividend rights from January 1, 2025 and are listed under the same ISIN DE0005659700 as the old shares.
About Eckert & Ziegler.
Eckert & Ziegler SE with more than 1.000 employees, is a leading specialist for isotope-related components in nuclear medicine and radiation therapy. The company offers a broad range of services and products for the radiopharmaceutical industry, from early development work to contract manufacturing and distribution. Eckert & Ziegler shares (ISIN DE0005659700) are listed in the TecDAX index of Deutsche Börse.
Contributing to saving lives.
Contact:
Eckert & Ziegler SE
Karolin Riehle, Investor Relations
Robert-Rössle-Str. 10, 13125 Berlin, Germany
Tel.: +49 (0) 30 / 94 10 84-138
05.08.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News – a service of EQS Group.
The issuer is solely responsible for the content of this announcement.
The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
| Language: | English |
| Company: | Eckert & Ziegler SE |
| Robert-Rössle-Str.10 | |
| 13125 Berlin | |
| Germany | |
| Phone: | +49 30 941084-138 |
| Fax: | +49 30 941084-0 |
| Internet: | www.ezag.de |
| ISIN: | DE0005659700 |
| WKN: | 565970 |
| Indices: | SDAX, TecDax, |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 2179638 |
| End of News | EQS News Service |
2179638 05.08.2025 CET/CEST